{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Tepotinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tepotinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tepotinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "tepotinib",
    "trial_2_text": "Tepotinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Tepotinib Supplement: 60 participants will take Tepotinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tepotinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tepotinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.4467483460903168,
      "78": 0.30092376470565796,
      "123": 0.2869904637336731,
      "189": 0.28243961930274963,
      "64": 0.27060696482658386,
      "188": 0.26687514781951904,
      "17": 0.22004222869873047,
      "20": 0.21461555361747742,
      "9": 0.21174082159996033,
      "67": 0.20943506062030792,
      "21": 0.20456534624099731,
      "37": 0.2018623948097229,
      "46": 0.19527840614318848,
      "243": 0.1800137758255005,
      "77": 0.17547625303268433,
      "228": 0.17311447858810425,
      "49": 0.16829298436641693,
      "68": 0.1671653836965561,
      "177": 0.16336733102798462,
      "136": 0.14836303889751434,
      "257": 0.1470676213502884,
      "200": 0.1431024968624115,
      "179": 0.14271870255470276,
      "101": 0.1415967494249344,
      "173": 0.13943801820278168,
      "350": 0.13170099258422852,
      "261": 0.12887144088745117,
      "191": 0.12804850935935974,
      "29": 0.12552905082702637,
      "104": 0.12238241732120514,
      "126": 0.11677734553813934,
      "211": 0.11406262218952179,
      "82": 0.11217331886291504,
      "193": 0.10964091867208481,
      "14": 0.1090364083647728,
      "454": 0.10700632631778717,
      "239": 0.10658109188079834,
      "5": 0.106528639793396,
      "85": 0.10551489144563675,
      "114": 0.10505780577659607,
      "2": 0.10253530740737915,
      "212": 0.10226950794458389,
      "79": 0.10194616764783859,
      "28": 0.10098615288734436,
      "35": 0.09922335296869278,
      "116": 0.0973471850156784,
      "131": 0.09717082977294922,
      "204": 0.09674103558063507,
      "76": 0.09516804665327072,
      "180": 0.09510481357574463,
      "72": 0.09396480768918991,
      "98": 0.09381604194641113,
      "249": 0.09305418282747269,
      "18": 0.09166746586561203,
      "27": 0.09014759212732315,
      "69": 0.08945494890213013,
      "36": 0.08940191566944122,
      "253": 0.08828595280647278,
      "130": 0.08343178033828735,
      "341": 0.08263308554887772,
      "38": 0.08229421079158783,
      "4": 0.07951300591230392,
      "102": 0.07938621938228607,
      "234": 0.07717972248792648,
      "186": 0.07704869657754898,
      "355": 0.07596492022275925,
      "371": 0.07570415735244751,
      "30": 0.07539599388837814,
      "441": 0.07479846477508545,
      "343": 0.0743584856390953,
      "194": 0.07404279708862305,
      "61": 0.07280593365430832,
      "288": 0.07117695361375809,
      "147": 0.07094717025756836,
      "382": 0.07085344195365906,
      "396": 0.06980487704277039,
      "122": 0.06958918273448944,
      "351": 0.06619101762771606,
      "269": 0.06525041908025742,
      "86": 0.0652434229850769,
      "466": 0.06507977098226547,
      "282": 0.06502628326416016,
      "94": 0.06483468413352966,
      "339": 0.06441104412078857,
      "535": 0.06395591050386429,
      "221": 0.06332441419363022,
      "99": 0.06294657289981842,
      "151": 0.06226307153701782,
      "124": 0.06190072372555733,
      "352": 0.06171060726046562,
      "337": 0.060397159308195114,
      "286": 0.059969428926706314,
      "256": 0.059716615825891495,
      "108": 0.05931632220745087,
      "83": 0.057848114520311356,
      "422": 0.057353731244802475,
      "218": 0.05662369728088379,
      "153": 0.05536350980401039,
      "457": 0.05528872087597847,
      "97": 0.05499553680419922
    },
    "trial_2_ae": {
      "87": 0.4467483460903168,
      "78": 0.30092376470565796,
      "123": 0.2869904637336731,
      "189": 0.28243961930274963,
      "64": 0.27060696482658386,
      "188": 0.26687514781951904,
      "17": 0.22004222869873047,
      "20": 0.21461555361747742,
      "9": 0.21174082159996033,
      "67": 0.20943506062030792,
      "21": 0.20456534624099731,
      "37": 0.2018623948097229,
      "46": 0.19527840614318848,
      "243": 0.1800137758255005,
      "77": 0.17547625303268433,
      "228": 0.17311447858810425,
      "49": 0.16829298436641693,
      "68": 0.1671653836965561,
      "177": 0.16336733102798462,
      "136": 0.14836303889751434,
      "257": 0.1470676213502884,
      "200": 0.1431024968624115,
      "179": 0.14271870255470276,
      "101": 0.1415967494249344,
      "173": 0.13943801820278168,
      "350": 0.13170099258422852,
      "261": 0.12887144088745117,
      "191": 0.12804850935935974,
      "29": 0.12552905082702637,
      "104": 0.12238241732120514,
      "126": 0.11677734553813934,
      "211": 0.11406262218952179,
      "82": 0.11217331886291504,
      "193": 0.10964091867208481,
      "14": 0.1090364083647728,
      "454": 0.10700632631778717,
      "239": 0.10658109188079834,
      "5": 0.106528639793396,
      "85": 0.10551489144563675,
      "114": 0.10505780577659607,
      "2": 0.10253530740737915,
      "212": 0.10226950794458389,
      "79": 0.10194616764783859,
      "28": 0.10098615288734436,
      "35": 0.09922335296869278,
      "116": 0.0973471850156784,
      "131": 0.09717082977294922,
      "204": 0.09674103558063507,
      "76": 0.09516804665327072,
      "180": 0.09510481357574463,
      "72": 0.09396480768918991,
      "98": 0.09381604194641113,
      "249": 0.09305418282747269,
      "18": 0.09166746586561203,
      "27": 0.09014759212732315,
      "69": 0.08945494890213013,
      "36": 0.08940191566944122,
      "253": 0.08828595280647278,
      "130": 0.08343178033828735,
      "341": 0.08263308554887772,
      "38": 0.08229421079158783,
      "4": 0.07951300591230392,
      "102": 0.07938621938228607,
      "234": 0.07717972248792648,
      "186": 0.07704869657754898,
      "355": 0.07596492022275925,
      "371": 0.07570415735244751,
      "30": 0.07539599388837814,
      "441": 0.07479846477508545,
      "343": 0.0743584856390953,
      "194": 0.07404279708862305,
      "61": 0.07280593365430832,
      "288": 0.07117695361375809,
      "147": 0.07094717025756836,
      "382": 0.07085344195365906,
      "396": 0.06980487704277039,
      "122": 0.06958918273448944,
      "351": 0.06619101762771606,
      "269": 0.06525041908025742,
      "86": 0.0652434229850769,
      "466": 0.06507977098226547,
      "282": 0.06502628326416016,
      "94": 0.06483468413352966,
      "339": 0.06441104412078857,
      "535": 0.06395591050386429,
      "221": 0.06332441419363022,
      "99": 0.06294657289981842,
      "151": 0.06226307153701782,
      "124": 0.06190072372555733,
      "352": 0.06171060726046562,
      "337": 0.060397159308195114,
      "286": 0.059969428926706314,
      "256": 0.059716615825891495,
      "108": 0.05931632220745087,
      "83": 0.057848114520311356,
      "422": 0.057353731244802475,
      "218": 0.05662369728088379,
      "153": 0.05536350980401039,
      "457": 0.05528872087597847,
      "97": 0.05499553680419922
    }
  },
  "safety": {
    "trial_1_safety": 0.40755242109298706,
    "trial_2_safety": 0.40755242109298706
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4818001091480255
  }
}